EAA conventions are scheduled biannually
The EAA is planning to hold conventions with invited participants from all stakeholder groups to discuss key challenges within the European access environment.
The agenda will include both, a ‘top-down’ health policy perspective by covering key market access strategy trends as well as a ‘bottom-up’ granular HTA perspective by identifying and discussing the most heterogeneous and controversial HTA procedures across Europe.
Where feasible, conventions or individual sessions will be made accessible to a wider audience via online-streaming. Further, the proceedings of the EAA conventions will be published.
Current / Upcoming Convention
NOW AVAILABLE:
EAA Convention Proceedings Issue #7
(click image to download the pdf)
EAA Spring Convention 2025
Approaching Performance Measurement for EU HTA
April 3rd, 2025 9:00 AM to 17:30 PM
in Berlin, Germany
We will discuss the definition of success and measurable success criteria for EU HTA from each stakeholder's point of view with our expert panel including Giovanna Scroccaro, Maya Matthews, Andrew Wilson, Ansgar Hebborn, Bruno Falissard, Bernhard Wörmann, Jürgen Wasem, Marcus Guardian, Niklas Hedberg, Rui Santos Ivo and many more.
Keynote presentations and round table discussions will take place in the morning
(9:00 AM - 12:30 PM),
in-depth discussions in break-out sessions will take place in the afternoon
(13:30 PM - 17:30 PM).
Agenda*:
Public Session
09:00 - Welcome & Setting the Scene (Petra Nies, Jürgen Wasem, Jörg Ruof)
09:15 - Impulse Presentations - Expectations and Perspectives for Defining Success
(Maya Matthews, Niklas Hedberg, Rui Santos Ivo, Bruno Falissard, Ansgar Hebborn, Andrew Wilson)
followed by Plenary Discussion
11:15 - Roundtable Session (Josephine Mosset, Bernhard Wörmann, Michael Berntgen, Giovanna Scroccaro)
- Lunchbreak -
Working Session
13:30 - Setting the Scene (Marcus Guardian, Bernhard Wörmann)
13:40 - EU HTAR revisited - Embedded Performance Criteria (Christian Dierks)
14:00 - Break-Out Sessions - Approaching EU HTA Performance Measurement from Various Perspectives
16:30 - Report Back from Break-Outs & Plenary Discussion
17:30 - End of Convention
*final agenda and speakers are subject to change
Recent Conventions
Video-recordings of the EAA Fall Convention, October 2024,
EU HTA: Transitioning from Preparation to Implementation - Approaching the Pain Points
Welcome by Fabrizio Gianfrate (University of Ferrara) and Jörg Ruof (EAA Secretariat)
Dirk Van den Steen
(Deputy Head of Unit at DG Santé, European Commission)
Marco Marchetti
(Co-Chair at HTA Coordination Group)
Robert Giovanni Nisticò (President at AIFA)
Elias Pèan
(Head of Oncology and Radiopharmaceuticals, EMA)
Robin Doeswijk
(Head of European Affairs, EHA)
François Houÿez
(Director of Treatment Information and Access, EURORDIS)
Bernhard Wörmann
(Medical Superintendent at DGHO & Charité University Medicine)
Nathalie Largeron
(Global Head of HTA Strategy, Sanofi)
Panel Discussion
(E. Pèan, R. Doeswijk, F. Houÿez, B. Wörmann, N. Largeron, Video: M. Marchetti)
Video-recordings of the EAA Spring Convention, April 2024,
EU HTA - Finding the Right Balance
Maureen Rutten-van Mölken
(Head of HTA Department at ESHPM, Erasmus University)
Maya Matthews
(Head of Unit at DG Santé, European Commission)
Bernhard Wörmann
(Medical Superintendant at DGHO & Charité University Medicine)
Antonella Cardone
(CEO at Cancer Patients Europe)
Maiwenn Al
(HTA Department at ESHPM, Erasmus University)
Stefan Lange
(former Deputy Head at IQWiG)
Francesco Pignatti
(Scientific Advisor for Oncology at EMA)
Elisabeth de Vries
(Cancer Medicines Committee & MCBS Working Group at ESMO)
Laetitia Mariani
(HTA Collaborations Lead at Abbvie)
Panel Discussion
(B. Wörmann, A. Cardone, M. Al, S. Lange, F. Pignatti, E. de Vries, L. Mariani)
Carin Uyl-de Groot
(HTA Department at ESHPM, Erasmus University)
Michael Ermisch
(Head of Department AMNOG G-BA at GKV-SV
Video-recordings of the EAA Fall Convention, October 2023,
Haemato- / Oncology - A Pace Maker for EU HTA:
Caroline Pothet
(Head of Advanced Therapies and Haematological Diseases at EMA)
Roisin Adams
(Chair of the HTA Coordination Group)
Elisabeth de Vries
(Cancer Medicines Committee & MCBS Working Group at ESMO)
César Hernández García
(Director General of Common NHS Portfolio and Pharmacy, Ministry of Health Spain)
Martin Kaiser
(European Hematology Association)
Bernhard Wörmann
(Medical Superintendant at German Society for Hematology and Oncology
(DGHO))
Brian Cuffel
(VP & Head of Market Access Oncology at Bayer Pharmaceuticals)
Panel Discussion:
(C. Pothet, R. Adams, E. de Vries, M. Kaiser, B. Wörmann, B. Cuffel; O. Solà-Morales, J. Ruof)
Video-recordings of the EAA Spring Convention, April 2023,
Midterms & Status of the Preparation Phase of the EU HTA Regulation:
Maya Matthews
(Head of Unit at DG Santé, European Commission)
Michael Berntgen
(Head of Scientific Evidence Generation Department, EMA)
Valentina Strammiello
(Director of Programmes, European Patients’ Forum)
Renato Bernardini
(Professor of Pharmacology, University of Catania School of Medicine & Deputy President, AIFA)
Michal Ermisch
(Division of Pharmaceuticals, National Association of Statutory Health Insurance Funds, Germany)
Ansgar Hebborn
(Head, European Access Policy Affairs, Roche & Chair of the HTA Working Group, EFPIA)
Andrew Wilson
(Chair, Pharmaceutical Benefits Advisory Committee, Australian Department of Health and Aged Care & Co-Director, Menzies Centre for Health Policy and Economics, University of Sydney)
Panel Discussion:
(M. Matthews, M. Berntgen, V. Strammiello, R. Bernardini, M. Ermisch, A. Hebborn, A. Wilson)
Click here for the complete proceedings of past EAA Conventions.